Literature DB >> 11770113

Emerging Leishmania/HIV co-infection in Africa.

D Wolday1, N Berhe, H Akuffo, P Desjeux, S Britton.   

Abstract

The HIV/AIDS pandemic is spreading at an alarmingly high rate in Africa. Leishmaniasis is also highly prevalent in the continent. Despite the emergence of Leishmania/HIV co-infection in Africa, the numbers reported are disproportionately low. Moreover, the number of cases of co-infection is expected to rise in Africa owing to the simultaneous spread of the two infectious diseases and their increasingly overlapping geographical distribution.

Entities:  

Mesh：

Year:  2001        PMID： 11770113     DOI： 10.1007/s004300100082

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


  13 in total

1.  Enzyme-linked immunosorbent assays for diagnosis of leishmaniasis in patients coinfected with human immunodeficiency virus.

Authors:  Subhash C Arya
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 2.  Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 3.  The genetics of Leishmania virulence.

Authors:  Eugenia Bifeld; Joachim Clos
Journal:  Med Microbiol Immunol       Date:  2015-06-06       Impact factor: 3.402

4.  New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.

Authors:  Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

Review 5.  Potential of Piper spp. as a source of new compounds for the leishmaniases treatment.

Authors:  Juliana Figueiredo Peixoto; Ygor Jessé Ramos; Davyson de Lima Moreira; Carlos Roberto Alves; Luiz Filipe Gonçalves-Oliveira
Journal:  Parasitol Res       Date:  2021-07-10       Impact factor: 2.289

Review 6.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

Review 7.  The immunology of Leishmania/HIV co-infection.

Authors:  Ifeoma Okwor; Jude Eze Uzonna
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

8.  Decreased memory T-cell response and function in human immunodeficiency virus-infected patients with tegumentary leishmaniasis.

Authors:  Luana Leandro Gois; Sanjay Mehta; Maria Zilma Andrade Rodrigues; Robert T Schooley; Roberto Badaró; Maria Fernanda Rios Grassi
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-10-02       Impact factor: 2.743

9.  In Silico Insights into the Mechanism of Action of Epoxy-α-Lapachone and Epoxymethyl-Lawsone in Leishmania spp.

Authors:  Juliana Figueiredo Peixoto; Adriane da Silva Oliveira; Patrícia Queiroz Monteiro; Luiz Filipe Gonçalves-Oliveira; Valter Viana Andrade-Neto; Vitor Francisco Ferreira; Franklin Souza-Silva; Carlos Roberto Alves
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

10.  Proteomic analysis of the secretome of Leishmania donovani.

Authors:  J Maxwell Silverman; Simon K Chan; Dale P Robinson; Dennis M Dwyer; Devki Nandan; Leonard J Foster; Neil E Reiner
Journal:  Genome Biol       Date:  2008-02-18       Impact factor: 13.583
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.